AB110. Efficacy and safety of mTOR inhibitor in the treatment of renal cell cancer: a meta-analysis

BACKGROUND: Treatment for metastatic renal cell cancer (mRCC) has advanced dramatically with understanding of the pathogenesis of the disease. New treatment options may provide improved median progression-free survival (MPFS). We aimed to determine the relative effectiveness of new therapies in this...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Transl Androl Urol
Main Authors: Zhang, Keke, Yan, Fei, Wang, Fuli, Yuan, Jianlin
Format: Artigo
Sprog:Inglês
Udgivet: AME Publishing Company 2014
Fag:
Abstract Publication Urology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4708334/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2014.s110
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker